Search Result "TCR"
Identification of Vβ7.1_H3F7 as a Therapeutic Gene Encoding TCR Specific to Hepatocellular Carcinoma
Journal: Current Gene Therapy
Volume: 14 Issue: 5 Year: 2014 Page: 389-399
Author(s): Shulin Huang,Han Shen,Zhiming Li,Sung-Kay Chiu,Runsheng Ruan,Lanfeng Xiao,Chi-Meng Tzeng
The TCR/CD3 Complex: Opening the Gate to Successful Vaccination
Journal: Current Pharmaceutical Design
Volume: 15 Issue: 2 Year: 2009 Page: 3290-3300
Author(s): Pilar Portoles, Jose M. Rojo
Major Highlights of the CAR-TCR Summit, Boston, 2016
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17 Issue: 10 Year: 2017 Page: 1344-1350
Author(s): Vita Golubovskaya,Robert Berahovich,Shirley Xu,Hizkia Harto,Lijun Wu
TCR Peptide Vaccination in Multiple Sclerosis: Boosting a Deficient Natural Regulatory Network that may Involve TCR-Specific CD4+CD25+ Treg Cells
Journal: Current Drug Targets - Inflammation & Allergy
Volume: 4 Issue: 2 Year: 2005 Page: 217-229
Author(s): Arthur A. Vandenbark
Systemic Immunomodulation of Autoimmune Disease Using MHC-Derived Recombinant TCR Ligands
Journal: Current Drug Targets - Inflammation & Allergy
Volume: 4 Issue: 2 Year: 2005 Page: 185-193
Author(s): Gregory G. Burrows
HLA and TCR Recognition of Medications in Severe Cutaneous Adverse Reactions
Journal: Current Immunology Reviews (Discontinued)
Volume: 10 Issue: 1 Year: 2014 Page: 51-61
Author(s): Ren-You Pan,Yi-Chih Wu,Wen-Hung Chung,Shuen-Iu Hung
Therapeutic Blockade of TCR Signal Transduction and Co-Stimulation in Autoimmune Disease
Journal: Current Drug Targets - Inflammation & Allergy
Volume: 4 Issue: 2 Year: 2005 Page: 205-216
Author(s): Laurence M. Howard, Adam P. Kohm, Carol L. Castaneda, Stephen D. Miller
Negative Regulation of TCR Signaling in Immunological Tolerance: Taming Good and Evil
Journal: Current Immunology Reviews
Volume: 4 Issue: 4 Year: 2008 Page: 190-198
Author(s): Martina Gatzka, Craig M. Walsh
Modulation of T Cell Immunity by TCR / pMHC Dwell Time and Activating / Inhibitory Receptor Pairs on the Antigen-Presenting Cell
Journal: Current Pharmaceutical Design
Volume: 9 Issue: 3 Year: 2003 Page: 233-244
Author(s): Alexis M. Kalergis
MHC Class I TCR Engineered Anti-Tumor CD4 T Cells: Implications For Cancer Immunotherapy
Journal: Endocrine, Metabolic & Immune Disorders - Drug Targets
Volume: 9 Issue: 4 Year: 2009 Page: 344-352
Author(s): Arvind Chhabra